Trial Profile
Carboplatin With Following Taxol Therapy Under Additional Application of Epoetin Alfa (ERYPO) With Female Patients With Advanced Ovarian Cancer FIGO IA/G3 - IV
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2019
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary) ; Paclitaxel (Primary) ; Carboplatin
- Indications Ovarian cancer
- Focus Therapeutic Use
- 28 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Oct 2005 New trial record.